Antimicrobial nanomedicine for ocular bacterial and fungal infection
Authors:
- 11 April 2021
- journal article
- research article
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 11 (4) , 1352-1375
Abstract
Ocular infection induced by bacteria and fungi is a major cause of visual impairment and blindness. Topical administration of antibiotics remains the first-line treatment, as effective eradication of pathogens is the core of the anti-infection strategy. Whereas, eye drops lack efficiency and have relatively low bioavailability. Intraocular injection may cause concurrent ocular damage and secondary infection. In addition, antibiotic-based management can be limited by the low sensitivity to multidrug-resistant bacteria. Nanomedicine is proposed as a prospective, effective, and noninvasive platform to mediate ocular delivery and combat pathogen or even resistant strains. Nanomedicine can not only carry antimicrobial agents to fight against pathogens but also directly active microbicidal capability, killing pathogens. More importantly, by modification, nanomedicine can achieve enhanced residence time and release time on the cornea, and easy penetration through corneal tissues into anterior and posterior segments of the eye, thus improving the therapeutic effect for ocular infection. In this review, several categories of antimicrobial nanomedicine are systematically discussed, where the efficiency and possibility of further embellishment and improvement to adapt to clinical use are also investigated. All in all, novel antimicrobial nanomedicine provides potent and prospective ways to manage severe and refractory ocular infections. Graphical abstractKeywords
Funding Information
- Natural Science Foundation of China (22005265)
- Natural Science Foundation of China (81870641)
- National Key R&D Program of China (2018YFC1106104)
- Key Research and Development Program of Zhejiang Province (2020C03035)
- Joint Funds of the Zhejiang Provincial Natural Science Foundation of China (LBY21E030002)
- Zhejiang TCM Science and Technology Program (2021ZQ053)
- Zhejiang Provincial Ten Thousand Talents Program (2018R52001)
This publication has 212 references indexed in Scilit:
- The use of diffuse laser photonic energy and indocyanine green photosensitiser as an adjunct to periodontal therapyBritish Dental Journal, 2013
- Dopamine‐Melanin Colloidal Nanospheres: An Efficient Near‐Infrared Photothermal Therapeutic Agent for In Vivo Cancer TherapyAdvanced Materials, 2012
- Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studiesNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Magnetoferritin nanoparticles for targeting and visualizing tumour tissuesNature Nanotechnology, 2012
- Nitric oxide release: Part II. Therapeutic applicationsChemical Society Reviews, 2012
- Nitric oxide release: Part I. Macromolecular scaffoldsChemical Society Reviews, 2012
- pH-Tunable Oxidase-Like Activity of Cerium Oxide Nanoparticles Achieving Sensitive Fluorigenic Detection of Cancer Biomarkers at Neutral pHAnalytical Chemistry, 2011
- Au@Pt nanostructures as oxidase and peroxidase mimetics for use in immunoassaysBiomaterials, 2011
- Gold Nanocages as Photothermal Transducers for Cancer TreatmentSmall, 2010
- Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nature Reviews Microbiology, 2005